Launching of Zolpidem tablet in the US Market

This is for information of all concerned that the Board of Directors of The ACME Laboratories Ltd. in its 119th Meeting held on 14 October 2020 during 3.30 p.m. to 5.30 p.m. through Digital Platform noted with immense pleasure, the launching of Zolpidem (5 mg. and 10mg.) tablet in the US Market through contract manufacturing.

It may be noted that exploring in the US Market has been one of the ACME’s most ambitious and dream projects which will generate yearly earnings of US$ 50,000.00 approximately.

The Price Sensitive Information (PSI) is also available in the website of the Company at